• Je něco špatně v tomto záznamu ?

Mutual influence of selenium nanoparticles and FGF2-STAB® on biocompatible properties of collagen/chitosan 3D scaffolds: in vitro and ex ovo evaluation

J. Muchová, V. Hearnden, L. Michlovská, L. Vištejnová, A. Zavaďáková, K. Šmerková, S. Kočiová, V. Adam, P. Kopel, L. Vojtová

. 2021 ; 19 (1) : 103. [pub] 20210413

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22004455

Grantová podpora
17-29874A Ministerstvo Zdravotnictví Ceské Republiky
CZ.02.1.01/0.0/0.0/16_019/0000787 Ministerstvo Školství, Mládeže a Tělovýchovy
CEITEC VUT/FEKT-J-20-6146 Vysoké Učení Technické v Brně
CZ.02.1.01/0.0/0.0/16_025/0007314 European Regional Development Fund
NV17-29874A MZ0 CEP - Centrální evidence projektů

In a biological system, nanoparticles (NPs) may interact with biomolecules. Specifically, the adsorption of proteins on the nanoparticle surface may influence both the nanoparticles' and proteins' overall bio-reactivity. Nevertheless, our knowledge of the biocompatibility and risk of exposure to nanomaterials is limited. Here, in vitro and ex ovo biocompatibility of naturally based crosslinked freeze-dried 3D porous collagen/chitosan scaffolds, modified with thermostable fibroblast growth factor 2 (FGF2-STAB®), to enhance healing and selenium nanoparticles (SeNPs) to provide antibacterial activity, were evaluated. Biocompatibility and cytotoxicity were tested in vitro using normal human dermal fibroblasts (NHDF) with scaffolds and SeNPs and FGF2-STAB® solutions. Metabolic activity assays indicated an antagonistic effect of SeNPs and FGF2-STAB® at high concentrations of SeNPs. The half-maximal inhibitory concentration (IC50) of SeNPs for NHDF was 18.9 µg/ml and IC80 was 5.6 µg/ml. The angiogenic properties of the scaffolds were monitored ex ovo using a chick chorioallantoic membrane (CAM) assay and the cytotoxicity of SeNPs over IC80 value was confirmed. Furthermore, the positive effect of FGF2-STAB® at very low concentrations (0.01 µg/ml) on NHDF metabolic activity was observed. Based on detailed in vitro testing, the optimal concentrations of additives in the scaffolds were determined, specifically 1 µg/ml of FGF2-STAB® and 1 µg/ml of SeNPs. The scaffolds were further subjected to antimicrobial tests, where an increase in selenium concentration in the collagen/chitosan scaffolds increased the antibacterial activity. This work highlights the antimicrobial ability and biocompatibility of newly developed crosslinked collagen/chitosan scaffolds involving FGF2-STAB® and SeNPs. Moreover, we suggest that these sponges could be used as scaffolds for growing cells in systems with low mechanical loading in tissue engineering, especially in dermis replacement, where neovascularization is a crucial parameter for successful skin regeneration. Due to their antimicrobial properties, these scaffolds are also highly promising for tissue replacement requiring the prevention of infection.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004455
003      
CZ-PrNML
005      
20220127145229.0
007      
ta
008      
220113s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12951-021-00849-w $2 doi
035    __
$a (PubMed)33849566
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Muchová, Johana $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic
245    10
$a Mutual influence of selenium nanoparticles and FGF2-STAB® on biocompatible properties of collagen/chitosan 3D scaffolds: in vitro and ex ovo evaluation / $c J. Muchová, V. Hearnden, L. Michlovská, L. Vištejnová, A. Zavaďáková, K. Šmerková, S. Kočiová, V. Adam, P. Kopel, L. Vojtová
520    9_
$a In a biological system, nanoparticles (NPs) may interact with biomolecules. Specifically, the adsorption of proteins on the nanoparticle surface may influence both the nanoparticles' and proteins' overall bio-reactivity. Nevertheless, our knowledge of the biocompatibility and risk of exposure to nanomaterials is limited. Here, in vitro and ex ovo biocompatibility of naturally based crosslinked freeze-dried 3D porous collagen/chitosan scaffolds, modified with thermostable fibroblast growth factor 2 (FGF2-STAB®), to enhance healing and selenium nanoparticles (SeNPs) to provide antibacterial activity, were evaluated. Biocompatibility and cytotoxicity were tested in vitro using normal human dermal fibroblasts (NHDF) with scaffolds and SeNPs and FGF2-STAB® solutions. Metabolic activity assays indicated an antagonistic effect of SeNPs and FGF2-STAB® at high concentrations of SeNPs. The half-maximal inhibitory concentration (IC50) of SeNPs for NHDF was 18.9 µg/ml and IC80 was 5.6 µg/ml. The angiogenic properties of the scaffolds were monitored ex ovo using a chick chorioallantoic membrane (CAM) assay and the cytotoxicity of SeNPs over IC80 value was confirmed. Furthermore, the positive effect of FGF2-STAB® at very low concentrations (0.01 µg/ml) on NHDF metabolic activity was observed. Based on detailed in vitro testing, the optimal concentrations of additives in the scaffolds were determined, specifically 1 µg/ml of FGF2-STAB® and 1 µg/ml of SeNPs. The scaffolds were further subjected to antimicrobial tests, where an increase in selenium concentration in the collagen/chitosan scaffolds increased the antibacterial activity. This work highlights the antimicrobial ability and biocompatibility of newly developed crosslinked collagen/chitosan scaffolds involving FGF2-STAB® and SeNPs. Moreover, we suggest that these sponges could be used as scaffolds for growing cells in systems with low mechanical loading in tissue engineering, especially in dermis replacement, where neovascularization is a crucial parameter for successful skin regeneration. Due to their antimicrobial properties, these scaffolds are also highly promising for tissue replacement requiring the prevention of infection.
650    _2
$a zvířata $7 D000818
650    _2
$a antibakteriální látky $7 D000900
650    _2
$a biokompatibilní materiály $x farmakologie $7 D001672
650    _2
$a buněčné linie $7 D002460
650    _2
$a chitosan $x farmakologie $7 D048271
650    _2
$a kolagen $x farmakologie $7 D003094
650    _2
$a fibroblastový růstový faktor 2 $x farmakologie $7 D016222
650    _2
$a fibroblasty $x účinky léků $7 D005347
650    _2
$a lidé $7 D006801
650    _2
$a testování materiálů $7 D008422
650    _2
$a nanočástice $x chemie $x terapeutické užití $7 D053758
650    _2
$a poréznost $7 D016062
650    _2
$a selen $x chemie $x farmakologie $7 D012643
650    _2
$a tkáňové inženýrství $x metody $7 D023822
650    12
$a tkáňové podpůrné struktury $7 D054457
650    _2
$a hojení ran $7 D014945
655    _2
$a časopisecké články $7 D016428
700    1_
$a Hearnden, Vanessa $u Department of Materials Science and Engineering, Kroto Research Institute, North Campus, University of Sheffield, Broad Lane, Sheffield, S3 7HQ, UK
700    1_
$a Michlovská, Lenka $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic
700    1_
$a Vištejnová, Lucie $u Biomedical Center, Medical Faculty in Pilsen, Charles University, Alej Svobody 1655/76, 323 00, Pilsen, Czech Republic
700    1_
$a Zavaďáková, Anna $u Biomedical Center, Medical Faculty in Pilsen, Charles University, Alej Svobody 1655/76, 323 00, Pilsen, Czech Republic
700    1_
$a Šmerková, Kristýna $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1665/1, 613 00, Brno, Czech Republic
700    1_
$a Kočiová, Silvia $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1665/1, 613 00, Brno, Czech Republic
700    1_
$a Adam, Vojtěch $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1665/1, 613 00, Brno, Czech Republic
700    1_
$a Kopel, Pavel $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic $u Department of Inorganic Chemistry, Faculty of Science, Palacky University, 17. Listopadu 12, 771 46, Olomouc, Czech Republic
700    1_
$a Vojtová, Lucy $u CEITEC-Central European Institute of Technology, Brno University of Technology, Purkynova 656/123, 612 00, Brno, Czech Republic. lucy.vojtova@ceitec.vutbr.cz
773    0_
$w MED00008237 $t Journal of nanobiotechnology $x 1477-3155 $g Roč. 19, č. 1 (2021), s. 103
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33849566 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145226 $b ABA008
999    __
$a ok $b bmc $g 1751807 $s 1155604
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 19 $c 1 $d 103 $e 20210413 $i 1477-3155 $m Journal of nanobiotechnology $n J Nanobiotechnology $x MED00008237
GRA    __
$a 17-29874A $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a CZ.02.1.01/0.0/0.0/16_019/0000787 $p Ministerstvo Školství, Mládeže a Tělovýchovy
GRA    __
$a CEITEC VUT/FEKT-J-20-6146 $p Vysoké Učení Technické v Brně
GRA    __
$a CZ.02.1.01/0.0/0.0/16_025/0007314 $p European Regional Development Fund
GRA    __
$a NV17-29874A $p MZ0
LZP    __
$a Pubmed-20220113

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...